Population with abnormal levels of CK-18-M30, FGF-21, IL-1Ra, PEDF and OPG seemed more possible to suffer from NASH, indicating these biomarkers have a crucial place in NASH prediction. Here, TNFRSF11B is linked to metabolic dysfunction-associated steatohepatitis.